Literature DB >> 22142307

Crosstalk and barriers between the electron carriers of the endoplasmic reticulum.

Gábor Bánhegyi1, Eva Margittai, András Szarka, József Mandl, Miklós Csala.   

Abstract

SIGNIFICANCE: The lumen of the endoplasmic reticulum (ER) constitutes a separate compartment with a special proteome and metabolome. The characteristic redox environment required for the optimal functioning of local pathways is defined by the redox couples of the main electron carriers. These molecules, glutathione, pyridine nucleotides, and ascorbic acid, are present within the ER, but their composition, concentration, and redox state are characteristically different from those observed in other subcellular compartments. Spatial and kinetic barriers contribute to the generation and maintenance of this special redox environment. RECENT ADVANCES: The ER redox has usually been considered from the perspective of oxidative protein folding, one of the major functions of the ER. Thus, the lumen has been described as a relatively oxidizing subcellular compartment. CRITICAL ISSUES: The ER redoxome has been scantily mapped. However, recent observations suggest that the redox systems in reduced and oxidized states are present simultaneously. The concerted actions of transmembrane uptake processes and local oxidoreductases as well as the absence of specific transport and enzyme activities maintain the oxidized state of the thiol-disulfide systems and the reduced state of the pyridine nucleotide redox systems. These states are prerequisites for the normal redox reactions localized in the ER. FUTURE DIRECTIONS: An outline of the interactions between the major electron carriers of the ER will contribute to a better understanding of human diseases related to ER redox homeostasis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22142307     DOI: 10.1089/ars.2011.4437

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  8 in total

Review 1.  Protein secretion and the endoplasmic reticulum.

Authors:  Adam M Benham
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-08-01       Impact factor: 10.005

Review 2.  Lipotoxicity in the liver.

Authors:  Veronika Zámbó; Laura Simon-Szabó; Péter Szelényi; Eva Kereszturi; Gábor Bánhegyi; Miklós Csala
Journal:  World J Hepatol       Date:  2013-10-27

Review 3.  Minireview: endoplasmic reticulum stress: control in protein, lipid, and signal homeostasis.

Authors:  József Mandl; Tamás Mészáros; Gábor Bánhegyi; Miklós Csala
Journal:  Mol Endocrinol       Date:  2013-01-24

Review 4.  Endoplasmic reticulum-mediated unfolded protein response and mitochondrial apoptosis in cancer.

Authors:  Tariq A Bhat; Ajay K Chaudhary; Sandeep Kumar; Jordan O'Malley; Joseph R Inigo; Rahul Kumar; Neelu Yadav; Dhyan Chandra
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2016-12-15       Impact factor: 10.680

Review 5.  Non-alcoholic fatty liver disease: what the clinician needs to know.

Authors:  Mariana Verdelho Machado; Helena Cortez-Pinto
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 6.  Traumatic Brain Injury: Ultrastructural Features in Neuronal Ferroptosis, Glial Cell Activation and Polarization, and Blood-Brain Barrier Breakdown.

Authors:  Delong Qin; Junmin Wang; Anh Le; Tom J Wang; Xuemei Chen; Jian Wang
Journal:  Cells       Date:  2021-04-24       Impact factor: 6.600

7.  Kinetic control by limiting glutaredoxin amounts enables thiol oxidation in the reducing mitochondrial intermembrane space.

Authors:  Kerstin Kojer; Valentina Peleh; Gaetano Calabrese; Johannes M Herrmann; Jan Riemer
Journal:  Mol Biol Cell       Date:  2014-11-12       Impact factor: 4.138

8.  Porcine Hepatic Response to Fumonisin B1 in a Short Exposure Period: Fatty Acid Profile and Clinical Investigations.

Authors:  Omeralfaroug Ali; Judit Szabó-Fodor; Hedvig Fébel; Miklós Mézes; Krisztián Balogh; Róbert Glávits; Melinda Kovács; Arianna Zantomasi; András Szabó
Journal:  Toxins (Basel)       Date:  2019-11-10       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.